Oncology & Cancer

Breast cancer resistance to CDK4/6 inhibitors arises in many ways

Breast cancer cells became resistant to therapeutics targeting CDK4/6, such as palbociclib (Ibrance), in multiple ways, and preclinical studies suggested different combinations of therapeutics may prevent and overcome the ...

Oncology & Cancer

HIV drug could stop skin cancer becoming drug-resistant

An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment, according to a Cancer Research UK-funded study published in Cancer Cell today.

Oncology & Cancer

Three hits to fight lung cancer

Although the most common type of lung cancer - non-small cell lung cancer (NSCLC) - has recently seen major treatment advances in some genetic subtypes, other subtypes continue to evade effective treatment. (New therapies ...

Oncology & Cancer

CK5 marks cisplatin-resistant ovarian cancer

A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ...

Oncology & Cancer

Staying one step ahead of cancer cells

BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials. In a study published in Nature today, a team of researchers at the Research Institute of Molecular ...

page 30 from 40